Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein

The re-emergence of the mpox pandemic poses considerable challenges to human health and societal development. There is an urgent need for effective prevention and treatment strategies against the mpox virus (MPXV). In this study, we focused on the A35R protein and created a chimeric A35R-Fc protein...

Full description

Saved in:
Bibliographic Details
Main Authors: Shimeng Bai, Yanxin Cui, Qibin Liao, Hongyang Yi, Zhonghui Liao, Gengwei Zhang, Fenfang Wu, Hongzhou Lu
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/17/1/116
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587274474225664
author Shimeng Bai
Yanxin Cui
Qibin Liao
Hongyang Yi
Zhonghui Liao
Gengwei Zhang
Fenfang Wu
Hongzhou Lu
author_facet Shimeng Bai
Yanxin Cui
Qibin Liao
Hongyang Yi
Zhonghui Liao
Gengwei Zhang
Fenfang Wu
Hongzhou Lu
author_sort Shimeng Bai
collection DOAJ
description The re-emergence of the mpox pandemic poses considerable challenges to human health and societal development. There is an urgent need for effective prevention and treatment strategies against the mpox virus (MPXV). In this study, we focused on the A35R protein and created a chimeric A35R-Fc protein by fusing the Fc region of IgG to its C-terminal. We then assessed its reactivity with A35R-specific antibodies and human convalescent plasma, as well as its immunogenicity. Our findings indicate that the A35R-Fc protein significantly enhances affinity to A35R antibodies compared to the commercially available A35R protein and exhibits considerable reactivity to human plasma. Additionally, mice immunized with A35R-Fc exhibited increased neutralizing antibody titers against the live MPXV. These results support the potential of Fc domain chimeric antigens as a strategy to enhance the efficacy of subunit vaccines targeting the MPXV.
format Article
id doaj-art-302f81013b4544ff8a34e7eb144ffc03
institution Kabale University
issn 1999-4915
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-302f81013b4544ff8a34e7eb144ffc032025-01-24T13:52:38ZengMDPI AGViruses1999-49152025-01-0117111610.3390/v17010116Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R ProteinShimeng Bai0Yanxin Cui1Qibin Liao2Hongyang Yi3Zhonghui Liao4Gengwei Zhang5Fenfang Wu6Hongzhou Lu7School of Public Health, Bengbu Medical University, Bengbu 233030, ChinaSchool of Public Health, Bengbu Medical University, Bengbu 233030, ChinaBio-Therapeutic Center, Shenzhen Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, ChinaBio-Therapeutic Center, Shenzhen Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, ChinaSchool of Public Health, Bengbu Medical University, Bengbu 233030, ChinaBio-Therapeutic Center, Shenzhen Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, ChinaBio-Therapeutic Center, Shenzhen Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People’s Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen 518112, ChinaSchool of Public Health, Bengbu Medical University, Bengbu 233030, ChinaThe re-emergence of the mpox pandemic poses considerable challenges to human health and societal development. There is an urgent need for effective prevention and treatment strategies against the mpox virus (MPXV). In this study, we focused on the A35R protein and created a chimeric A35R-Fc protein by fusing the Fc region of IgG to its C-terminal. We then assessed its reactivity with A35R-specific antibodies and human convalescent plasma, as well as its immunogenicity. Our findings indicate that the A35R-Fc protein significantly enhances affinity to A35R antibodies compared to the commercially available A35R protein and exhibits considerable reactivity to human plasma. Additionally, mice immunized with A35R-Fc exhibited increased neutralizing antibody titers against the live MPXV. These results support the potential of Fc domain chimeric antigens as a strategy to enhance the efficacy of subunit vaccines targeting the MPXV.https://www.mdpi.com/1999-4915/17/1/116mpoxmpox virusMPXVA35R proteinFc fusion protein
spellingShingle Shimeng Bai
Yanxin Cui
Qibin Liao
Hongyang Yi
Zhonghui Liao
Gengwei Zhang
Fenfang Wu
Hongzhou Lu
Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein
Viruses
mpox
mpox virus
MPXV
A35R protein
Fc fusion protein
title Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein
title_full Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein
title_fullStr Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein
title_full_unstemmed Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein
title_short Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein
title_sort enhanced immunogenicity and affinity with a35r fc based chimeric protein compared to mpxv a35r protein
topic mpox
mpox virus
MPXV
A35R protein
Fc fusion protein
url https://www.mdpi.com/1999-4915/17/1/116
work_keys_str_mv AT shimengbai enhancedimmunogenicityandaffinitywitha35rfcbasedchimericproteincomparedtompxva35rprotein
AT yanxincui enhancedimmunogenicityandaffinitywitha35rfcbasedchimericproteincomparedtompxva35rprotein
AT qibinliao enhancedimmunogenicityandaffinitywitha35rfcbasedchimericproteincomparedtompxva35rprotein
AT hongyangyi enhancedimmunogenicityandaffinitywitha35rfcbasedchimericproteincomparedtompxva35rprotein
AT zhonghuiliao enhancedimmunogenicityandaffinitywitha35rfcbasedchimericproteincomparedtompxva35rprotein
AT gengweizhang enhancedimmunogenicityandaffinitywitha35rfcbasedchimericproteincomparedtompxva35rprotein
AT fenfangwu enhancedimmunogenicityandaffinitywitha35rfcbasedchimericproteincomparedtompxva35rprotein
AT hongzhoulu enhancedimmunogenicityandaffinitywitha35rfcbasedchimericproteincomparedtompxva35rprotein